BioLineRx Ltd.
BioLineRx Ltd. (BLRX): 1 pipeline candidate · 1 upcoming catalyst · 4 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E 0.75 · 0% dilution
Lead: Phase 3
1 candidate
1 upcoming, next in ~1200d
N/A
A transparent, data-derived signal for BioLineRx Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$13.7M
Cash
$632K
Quarterly Burn
—
Runway
—
Revenue
—
Cash Runway vs Catalysts
Upcoming catalyst timeline.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| bl-8040 1.25 mg/kg + g-csf | Phase 3 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
11
Total value held
$67K
| Holder | Shares | Value |
|---|---|---|
| xtx topco ltd | 10,941 | $25K |
| susquehanna international group, llp | 10,200 | $24K |
| rhumbline advisers | 2,353 | $5K |
| bnp paribas financial markets | 1,800 | $4K |
| wells fargo & company/mn | 1,750 | $4K |
| citigroup inc | 1,728 | $4K |
| morgan stanley | 100 | $230 |
| osaic holdings, inc. | 26 | $59 |
| rockefeller capital management l.p. | 12 | $28 |
| danske bank a/s | 2 | $5 |
Showing top 10 of 11 institutional holders of BioLineRx Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in BioLineRx Ltd.'s pipeline?
BioLineRx Ltd. (BLRX) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is BioLineRx Ltd.'s lead drug candidate?
BioLineRx Ltd.'s most advanced tracked candidate is bl-8040 1.25 mg/kg + g-csf (Phase 3) for Multiple Myeloma.
What is BioLineRx Ltd.'s next catalyst?
BioLineRx Ltd.'s next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: A Phase III, Randomized, Placebo-Controlled, Multi-Centre Study Evaluating the Safety, Tolerability " — expected September 30, 2029.
What is BioLineRx Ltd.'s market capitalization?
BioLineRx Ltd.'s market capitalization is approximately $13.7M.
Who is the CEO of BioLineRx Ltd.?
Mr. Philip A. Serlin CPA, M.B.A. is the chief executive officer of BioLineRx Ltd. (BLRX).
Get the full picture on BioLineRx Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.